Tirzepatide: Regulatory Status and Clinical Research Context in Australia

Also known as: Mounjaro, Zepbound

What is Tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been the subject of international clinical research. It is a prescription medicine that has received regulatory approval in several countries including the United States. In Australia, tirzepatide is listed on the ARTG for specific indications and is available by prescription. This page provides general information about tirzepatide's regulatory and clinical context in Australia and is not medical advice.

Regulatory Status in Australia

Tirzepatide was approved by the TGA for type 2 diabetes management (Mounjaro) in 2023 and for weight management in late 2023/2024. It is available in Australia by prescription from AHPRA-registered medical practitioners. As with all prescription medicines, a thorough clinical assessment is required before prescribing. Compounded versions or alternative supply pathways may be available through compounding pharmacies under the TGA's regulatory framework. All listed clinics on Peptide Finder operate within the Australian regulatory framework.

Research Context

Tirzepatide has been studied in the international SURPASS (diabetes) and SURMOUNT (weight management) clinical trial programmes. Published peer-reviewed research has investigated its effects on metabolic markers and body weight. As a newer therapeutic agent compared to single-agonist GLP-1s, the long-term safety profile continues to be characterised through ongoing studies and post-market surveillance. The TGA evaluates this evidence when making approval decisions for registered indications. Individual prescribing decisions are made by the treating practitioner.

What This Means for Australians

Tirzepatide is TGA-approved for specific indications and available by prescription in Australia
An AHPRA-registered medical practitioner must assess suitability before prescribing
Consultations involve medical history review and discussion of treatment goals
Telehealth access is available through many clinics for patients across Australia
Use Peptide Finder to compare clinics offering weight management consultations

This page provides general information only and is not medical advice. Always speak with a qualified healthcare professional before starting any new medical treatment. Any prescribing decision is made by the treating practitioner after an individual clinical assessment.

Compare Clinics

26 clinics offering related consultations. Compare details, then contact the clinic that looks like the best fit.

Peptide Finder is a clinic directory only. We do not prescribe, supply, or advertise prescription medicines. Suitability is determined by the prescribing doctor at consultation.

Elite

GL Vitality Drips

Sydney, NSW

4.9(32)

Director-led, Australia-wide telehealth service connecting clients with AHPRA-registered doctors and licensed compounding pharmacies. Medical oversight is provided by Dr. Harrison Weisinger (Dr. Harry), an Australian family doctor with a PhD in preventative and evidence-based healthcare. Founded by Gemma - clients liaise directly with her throughout their program.

Injury RecoveryWeight ManagementMuscle & PerformancePlus more

Aus-wide delivery